Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2026-04-26 @ 10:31 AM
Study NCT ID:
NCT06999733
Status:
RECRUITING
Last Update Posted:
2025-05-31
First Post:
2025-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis
Sponsor:
Krystal Biotech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KB801-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None